Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 501-65-5 | MDL No. : | MFCD00004786 |
Formula : | C14H10 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | JRXXLCKWQFKACW-UHFFFAOYSA-N |
M.W : | 178.23 | Pubchem ID : | 10390 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 0.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 58.86 |
TPSA : | 0.0 Ų |
GI absorption : | Low |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -3.99 cm/s |
Log Po/w (iLOGP) : | 2.85 |
Log Po/w (XLOGP3) : | 4.78 |
Log Po/w (WLOGP) : | 3.17 |
Log Po/w (MLOGP) : | 5.24 |
Log Po/w (SILICOS-IT) : | 3.95 |
Consensus Log Po/w : | 4.0 |
Lipinski : | 1.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.59 |
Solubility : | 0.00457 mg/ml ; 0.0000257 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -4.51 |
Solubility : | 0.00549 mg/ml ; 0.0000308 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -4.99 |
Solubility : | 0.00181 mg/ml ; 0.0000101 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 2.25 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P301+P312-P302+P352-P304+P340-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | With Cp*Rh(H2O)3(OTf)2; oxygen; acetic anhydride In pentan-1-ol at 100℃; for 24 h; | The 4-aminochlorobenzene 1j (76.5 mg, 0 . 6mmol), 1, 2-diphenyl 2a (71.3 mg, 0 . 4mmol), Cp*Rh (H2O)3(OTf)2(11.8 mg, 5mol percent), acetic anhydride (59. 0μL, 0 . 6mmol), adding 2.0 ml in tertiary amyl alcohol , oxygen (1atm), 100 degrees reaction 24 hours after stop the reaction, add NaOH (48 mg, 1 . 2mmol) and methanol 2 ml after stirring one hour, column chromatography to obtain pure product 5-chloro-2,3-diphenyl indole 3ja. The product is white solid, yield 90percent. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
55% | With 2 mol% Pd/C; sodium carbonate In N,N-dimethyl-formamide at 140℃; for 144 h; Inert atmosphere | aryl bromide (1 mmol), alkyne (3 mmol), Na2CO3 (3 mmol), Pd/C (2 mo lpercent) and DMF (2 mL) were introduced in a sealed tube. The reactor was placed under stirring in a preheated oil bath at 120 °C or 140 °C after being flushed by argon. The reaction completion was monitored by GC. After cooling to room temperature, the reaction mixture was filtered through a celite pad, which was washed with EtOAc (100 mL). The resulting organic layer was then washed with Na2CO3 (2 .x. 40 mL) and brine (40 mL). The organic layer was dried over Na2SO4 and the solvent was removed under reduced pressure. If necessary (for the silylated compounds), the crude product could be fully deprotected by treatment with HCl 1 M before being purified by flash chromatography on silica. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
37% | Stage #1: With dmap; n-butyllithium; zirconocene dichloride In tetrahydrofuran; hexane at 20℃; for 1 h; Inert atmosphere Stage #2: at 20℃; for 12 h; Inert atmosphere |
General procedure: To a solution of Cp2ZrCl2 (1.2 mmol, 351 mg) in 5 mL THF, n-BuLi (2.4 mmol, 1.5 mL, 1.6 M in hexane) was added at−78 °C and the mixture was stirred for 1 h at the same temperature. To this solution, 4-dimethylaminopyridine (DMAP, 122 mg, 1.0 mmol) was added. The resulting mixture was warmed to room temperature and stirred for 1 h. Diphenylacetylene (1.0 mmol, 178 mg) was added and the mixture was stirred for 1 h at the same temperature. Subsequently, PhLi (2.0 mmol) was added and the solution was stirred for 12 h at room temperature. Then TCQ (2.0 mmol) was added and stirred for another 12 h to afford alkenylzirconocene 4a. The mixture was quenched with HCl solution to afford product 3a in 62percent isolated yield. |